Beyond sodium restriction, managing micronutrient intakes is important for medical nutrition therapy to control CKD, high blood pressure.

Sibeprenlimab clinically reduces proteinuria in adults with immunoglobulin A nephropathy (IgAN), according to data from a prespecified analysis of the phase 3 VISIONARY trial. The findings were ...